Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories
-
Form 4 RayzeBio, Inc. For: Feb 26 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 RayzeBio, Inc. For: Feb 26 Filed by: Viking Global Opportunities Drawdown Portfolio GP LLC
-
Form SC 13G/A RayzeBio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
APi Group Corporation (APG) Launches 8.13M Share Secondary Offering
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
-
Form SC 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Adaptive Biotechnologies Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Rallybio Corp Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A VALVOLINE INC Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Five9, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
-
ORIC Pharmaceuticals (ORIC) Prices 12.5M Share Offering at $10/sh
-
Form SC 13G STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 4D Molecular Therapeutic For: Jan 04 Filed by: Viking Global Opportunities GP LLC
-
Form 144 APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
-
Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G Five9, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form D/A Viking Global Opportunit
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Opportunit
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Equities
-
Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G RayzeBio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 RayzeBio, Inc. For: Sep 19 Filed by: Viking Global Opportunities Drawdown Portfolio GP LLC
-
Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
-
Walgreens Boots Alliance (WBA) and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
-
Form 4 Inhibrx, Inc. For: Aug 28 Filed by: VIKING GLOBAL INVESTORS LP